<SEC-DOCUMENT>0001680367-22-000014.txt : 20220512
<SEC-HEADER>0001680367-22-000014.hdr.sgml : 20220512
<ACCEPTANCE-DATETIME>20220512060217
ACCESSION NUMBER:		0001680367-22-000014
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220512
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220512
DATE AS OF CHANGE:		20220512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Shattuck Labs, Inc.
		CENTRAL INDEX KEY:			0001680367
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				812575858
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39593
		FILM NUMBER:		22915520

	BUSINESS ADDRESS:	
		STREET 1:		500 W. 5TH STREET
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
		BUSINESS PHONE:		512-900-4690

	MAIL ADDRESS:	
		STREET 1:		500 W. 5TH STREET
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sttk-20220512.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:277ccaaa-9ac8-485f-a13a-130f0df53a45,g:8a1a2fa4-acd3-4100-ad78-32c9fdee1805,d:88358909f40b422b8563bb6585ccfffb--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sttk-20220512</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl80L2ZyYWc6MjA4MDkxZTViMDczNGM3NThmZTNiOTU2MjA0ZDliNjcvdGFibGU6NDMwNTNkYWE5ZmNhNDg5YjhlYzc0MGQzZjBkNWRkMzMvdGFibGVyYW5nZTo0MzA1M2RhYTlmY2E0ODliOGVjNzQwZDNmMGQ1ZGQzM18wLTEtMS0xLTE0Mjg2_c743cb3e-062f-431b-8976-e7122e03b19e">0001680367</ix:nonNumeric><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl80L2ZyYWc6MjA4MDkxZTViMDczNGM3NThmZTNiOTU2MjA0ZDliNjcvdGFibGU6NDMwNTNkYWE5ZmNhNDg5YjhlYzc0MGQzZjBkNWRkMzMvdGFibGVyYW5nZTo0MzA1M2RhYTlmY2E0ODliOGVjNzQwZDNmMGQ1ZGQzM18xLTEtMS0xLTE0Mjg2_848ed7e1-0726-4357-a4bd-4cdfe5d5be92">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sttk-20220512.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-12</xbrli:startDate><xbrli:endDate>2022-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i88358909f40b422b8563bb6585ccfffb_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:99%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:99%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:99%">WASHINGTON, DC 20549 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTQ_1d9f910b-84e4-4dc8-86aa-be08ca3dbd54">8-K</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:99%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:99%">of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:99%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl8yMjU_41db24ab-ae4c-4fa1-a53d-f2293471c9d0">May 12, 2022</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20.5pt;font-weight:700;line-height:99%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTU_8eb49e27-8abf-4f66-b318-89f4cc9e96f5">Shattuck Labs, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:99%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.352%"><tr><td style="width:1.0%"></td><td style="width:34.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YjE0NzNjYmU5YzcwNDE3ZDg2ZDc0ZmRjMzE0M2ZhMGUvdGFibGVyYW5nZTpiMTQ3M2NiZTljNzA0MTdkODZkNzRmZGMzMTQzZmEwZV8wLTAtMS0xLTE0Mjg2_570b4ff6-4e9f-48c2-b763-1dd18bab1a1d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:73%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YjE0NzNjYmU5YzcwNDE3ZDg2ZDc0ZmRjMzE0M2ZhMGUvdGFibGVyYW5nZTpiMTQ3M2NiZTljNzA0MTdkODZkNzRmZGMzMTQzZmEwZV8wLTEtMS0xLTE0Mjg2_600d36c8-37b0-4f16-8236-e579f8f3fd5a">001-39593</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YjE0NzNjYmU5YzcwNDE3ZDg2ZDc0ZmRjMzE0M2ZhMGUvdGFibGVyYW5nZTpiMTQ3M2NiZTljNzA0MTdkODZkNzRmZGMzMTQzZmEwZV8wLTItMS0xLTE0Mjg2_af4fc0d3-7185-4965-bbdb-4543a9527309">81-2575858</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="padding-left:49.5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTY_b54f7276-585f-429a-bc0a-ca2f2ecf0dd2">500 W. 5th Street</ix:nonNumeric>, <ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MjE_ab990f7d-43ee-40d1-a5c8-c6d231e0a146">Suite 1200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTc_9ea9f573-488f-496b-8944-4fe8d5e5f2f2">Austin</ix:nonNumeric>, <ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTg_b2ff93f8-a2b8-423b-8c11-4fdf61654492">TX</ix:nonNumeric> <ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MjM_9ccbf416-a751-43aa-a451-71d8a06d0eda">78701</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 25.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:99%">(Address of principal executive offices including zip code)</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:99%">(<ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl8zNjY_dcc84cd2-7b76-44ec-b804-4d1204588a36">512</ix:nonNumeric>) <ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MjQ_67d1c586-410b-473f-b1cd-47e22e8de4b3">900-4690</ix:nonNumeric> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.673%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:85%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.429%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%"><br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl8xLTAtMS0xLTE0Mjg2_b5dc87a2-8776-4db6-908b-73b8e804fd00">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl8yLTAtMS0xLTE0Mjg2_a35ade2d-2005-4f70-a71a-98e9d3aae3d3">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl8zLTAtMS0xLTE0Mjg2_024445a3-19ef-4507-9e14-5de10bf652c8">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl80LTAtMS0xLTE0Mjg2_504b034b-f553-4b87-925e-417b64abd356">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Securities registered pursuance to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6M2I0MjhhN2YyZmRmNDZiNDg2MGZiNWI5ZjcxZjNjYTIvdGFibGVyYW5nZTozYjQyOGE3ZjJmZGY0NmI0ODYwZmI1YjlmNzFmM2NhMl8xLTAtMS0xLTE0Mjg2_19f06ca9-0d45-4c5b-80f1-30b608db958b">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6M2I0MjhhN2YyZmRmNDZiNDg2MGZiNWI5ZjcxZjNjYTIvdGFibGVyYW5nZTozYjQyOGE3ZjJmZGY0NmI0ODYwZmI1YjlmNzFmM2NhMl8xLTEtMS0xLTE0Mjg2_c10d3f17-4aa7-4218-80eb-f3187e3eac49">STTK</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6M2I0MjhhN2YyZmRmNDZiNDg2MGZiNWI5ZjcxZjNjYTIvdGFibGVyYW5nZTozYjQyOGE3ZjJmZGY0NmI0ODYwZmI1YjlmNzFmM2NhMl8xLTItMS0xLTE0Mjg2_1bc5b1fa-1f08-4e51-8a47-9855241b17de">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%"><br/></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6Y2ExOTdiMDgwMzRjNDIyZmFjOWRmMTY1MTczZDg5MjAvdGFibGVyYW5nZTpjYTE5N2IwODAzNGM0MjJmYWM5ZGYxNjUxNzNkODkyMF8xLTEtMS0xLTE0Mjg2_823a916b-9fb5-4853-a26a-bbfab4f86835">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6Y2ExOTdiMDgwMzRjNDIyZmFjOWRmMTY1MTczZDg5MjAvdGFibGVyYW5nZTpjYTE5N2IwODAzNGM0MjJmYWM5ZGYxNjUxNzNkODkyMF8yLTEtMS0xLTE0Mjg2_30bbac40-21dc-4583-adaf-573bf3ecb68a">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i88358909f40b422b8563bb6585ccfffb_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2022, Shattuck Labs, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated herein shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i88358909f40b422b8563bb6585ccfffb_10"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">Press release issued by Shattuck Labs, Inc. regarding its financial results for the quarter ended </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">March 31, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">Ma</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">y 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm"> 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_1q2022earningsrelease.htm">.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company&#8217;s Current Report on Form 8-K formatted in Inline XBRL.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i88358909f40b422b8563bb6585ccfffb_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shattuck Labs, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 12, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dr. Taylor Schreiber</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr.&#160;Taylor Schreiber</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(principal executive officer)</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>sttk_1q2022earningsrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4e95977f5b3741c9bc32d98b05a7f109_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:256px"></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights</font></div><div style="margin-top:6pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13pt">Dose escalation ongoing in Phase 1 clinical trial of SL-172154 in platinum-resistant ovarian cancer&#59; combination trial with liposomal doxorubicin on track to begin in 2H&#8217;2022&#59; full dose-escalation data in monotherapy and initial data in combination both expected in 1H&#8217;2023 &#8211;</font></div><div style="margin-top:6pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13pt">Dose escalation ongoing for Phase 1 clinical trial of SL-172154 in acute myeloid leukemia and higher-risk myelodysplastic syndromes with initial monotherapy and combination dose escalation data expected in 1H&#8217;2023 &#8211;</font></div><div style="margin-top:6pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13pt"> Enrollment ongoing for Phase 1 dose-escalation trial of SL-279252 with top-line data expected in 2H&#8217;2022 &#8211;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AUSTIN, TX and DURHAM, NC, May 12, 2022 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Shattuck Labs, Inc. (Shattuck) (NASDAQ&#58; STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the quarter ended March 31, 2022 and provided recent business highlights. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;We are now completing the monotherapy dose-escalation study for SL-172154 in ovarian cancer patients and are focused on the initiation and rapid clinical execution of multiple combination studies in both hematologic and solid tumors. This expansion is a critical step in establishing SL-172154 as both a first- and best-in-class CD47 inhibitor and CD40 agonist, and we continue to expect SL-172154 to differentiate from other CD47 inhibitors and CD40 agonists in terms of safety, pharmacodynamic activity, and efficacy in combinations. The next 18 months are shaping up to be a defining period for establishing CD47 inhibition as a key macrophage checkpoint in multiple indications, and we look forward to providing initial combination data from SL-172154 in the first half of 2023,&#8221; said Taylor Schreiber, M.D., Ph.D., and Chief Executive Officer of Shattuck.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter 2022 Recent Business Highlights and Other Recent Developments</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ARC Clinical-Stage Pipeline and Preclinical Pipeline</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SL-172154 (SIRP&#945;-Fc-CD40L)</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Continued Enrollment of SL-172154 Phase 1A Dose-Escalation Clinical Trial in Platinum-Resistant Ovarian Cancer&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This open-label, multi-center, dose-escalation clinical trial is evaluating the safety, tolerability, pharmacokinetics, anti-tumor activity, and pharmacodynamic effects of SL-172154 administered intravenously in patients with platinum resistant ovarian cancer. Full dose-escalation data from the trial are expected in the first half of 2023.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Phase 1B Clinical Trial of SL-172154 in Combination with Liposomal Doxorubicin Expected to Begin in the Second Half of 2022&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This clinical trial will evaluate the safety, tolerability, pharmacokinetics, anti-tumor activity, and pharmacodynamics effects of SL-172154 in combination with liposomal doxorubicin in patients with advanced, platinum-resistant ovarian cancer and is anticipated to begin enrollment in the second half of 2022. Initial combination data from the trial are expected in the first half of 2023. Additional combination trials with SL-172154 in ovarian cancer and novel agents are currently being planned.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Enrollment Continues in SL-172154 Phase 1A&#47;B Clinical Trial in Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS)&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trial is evaluating the safety, tolerability, pharmacokinetics, anti-tumor activity, and pharmacodynamic effects of SL-172154, as both monotherapy and in combination. In both HR-MDS and TP53 mutant AML, SL-172154 will be combined with azacitidine. In AML, SL-172154 will be evaluated in combination with both azacitidine and venetoclax. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initial data from the monotherapy and combination dose escalation portions of the trial are expected in the first half of 2023.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Data for Intratumorally Administered SL-172154 Phase 1 Clinical Trial in Squamous Cell Carcinoma of the Head and Neck or Skin to be Presented in the Second Half of 2022&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shattuck anticipates presenting data from the clinical trial in the second half of 2022.  Shattuck may continue further development of SL-172154 in squamous cell carcinoma of the head and neck (HNSCC) or skin (CSCC) via intravenous administration following selection of a recommended Phase 2 dose in ovarian cancer.</font></div><div style="margin-top:6pt;text-indent:-3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SL-279252 (PD1-Fc-OX40L)</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Continued Enrollment of SL-279252 Phase 1 Dose-Escalation Clinical Trial in Advanced Solid Tumors&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Enrollment of patients with primarily PD-L1 selected tumors continues in the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 1 open-label, multi-center, dose-escalation clinical trial to evaluate the safety, tolerability, pharmacokinetics, anti-tumor activity and pharmacodynamic effects of SL-279252 in patients with advanced solid tumors and lymphoma. Top-line data from all treated subjects across the full dose range are anticipated in the second half of 2022. </font></div><div style="margin-top:6pt;text-indent:-3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preclinical</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Presented </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preclinical Data on SL-9258</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">at AACR in April</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preclinical data for SL-9258 (TIGIT-Fc-LIGHT), a dual TIGIT inhibitor and HVEM&#47;LT&#946;R agonist, were presented at the American Association for Cancer Research Annual Meeting (AACR) in April 2022. These data, from studies in a mouse model, provided preclinical evidence for anti-tumor activity of the murine equivalent of SL-9258 in PD-1 acquired resistant tumors and increased tumor rejection in comparison to TIGIT blocking antibodies. In these preclinical models, TIGIT-Fc-LIGHT outperformed TIGIT blocking antibodies independent of PD-L1 or DNAM-1 (CD226) expression. TIGIT-Fc-LIGHT was also evaluated and well tolerated in non-human primates and observed similar on-target pharmacodynamic activity to what was characterized in the mouse model. Together, these results suggest that TIGIT-Fc-LIGHT may provide clinical benefit to patients that are refractory to conventional checkpoint blockade therapy.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Presented Preclinical Data at AACR on GADLEN Platform&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shattuck also presented preclinical data highlighting the potential of GADLENs to direct gamma delta T cells to kill tumor cells and, in the process, further elucidate tumor cell markers which are important for the therapeutic activity of gamma delta T cell-based therapies. Butyrophilin heterodimeric fusion proteins from Shattuck&#8217;s GADLEN platform showed enhanced tumor cell killing targeting CD19 and CD20 and demonstrated preclinical proof of concept in the treatment of cancer.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Clinical Pipeline Product Candidate to be Selected in 2022&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As Shattuck looks to advance its preclinical pipeline, a new product candidate from the ARC or GADLEN platform is anticipated to be selected in the second half of 2022. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Upcoming Events</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">H.C. Wainwright 2022 Global Investment Conference </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management will participate in investor one-on-one meetings and give a corporate presentation during the H.C. Wainwright 2022 Global Investment Conference from May 24-26, 2022. A live and archived audio webcast of the presentation will be available by visiting the Events &#38; Presentations section of the Company&#8217;s website.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter 2022 Financial Results</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Cash Position&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of March 31, 2022, cash and cash equivalents and short-term investments were $239.2 million, as compared to $321.2 million as of March 31, 2021.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Research and Development (R&#38;D) Expenses&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> R&#38;D expenses for the quarter ended March 31, 2022 were $19.2 million, as compared to $10.3 million for the quarter ended March 31, 2021. This increase was primarily driven by increases in process development costs and manufacturing of trial materials and personnel-related costs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">General and Administrative (G&#38;A) Expenses&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> G&#38;A expenses were $5.0 million for the quarter ended March 31, 2022, as compared to $4.4 million for the quarter ended March 31, 2021. This increase was primarily driven by increases in compensation related and other operating costs.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Net Income&#47;Loss&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net loss was $24.5 million for the quarter ended March 31, 2022, or $0.58 per basic and diluted share, as compared to a net loss of $11.8 million for the quarter ended March 31, 2021, or $0.28 per basic and diluted share.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Financial Guidance</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shattuck believes its cash and cash equivalents and short-term investments will be sufficient to fund its operations into the second half of 2024, beyond results from its Phase 1 clinical trials of SL-172154 and SL-279252. This cash runway guidance is based on the Company&#8217;s current operational plans and excludes any additional funding that may be received or business development or additional clinical development activities that may be undertaken.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About SL-172154</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SL-172154 (SIRP&#945;-Fc-CD40L) is an investigational ARC&#174; fusion protein designed to simultaneously inhibit the CD47&#47;SIRP&#945; checkpoint interaction and activate the CD40 costimulatory receptor to bolster an anti-tumor immune response in patients with advanced cancer. Two Phase 1 clinical trials are ongoing, the first for patients with advanced and platinum resistant ovarian cancer (NCT04406623) and the second for patients with AML and HR-MDS (NCT05275439).</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About SL-279252</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SL-279252 (PD1-Fc-OX40L) is an investigational ARC&#174; fusion protein designed to simultaneously inhibit the PD-1&#47;PD-L1 interaction and activate the OX40 receptor in patients with advanced cancers. A Phase 1 trial in patients with solid tumors and lymphoma is ongoing (NCT03894618).</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Shattuck Labs, Inc.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shattuck Labs, Inc. (NASDAQ&#58; STTK) is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck&#8217;s proprietary Agonist Redirected Checkpoint, ARC&#174;, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The company&#8217;s SL-172154 (SIRP&#945;-Fc-CD40L) program, which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in two Phase 1 trials. A second product candidate, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in solid tumors or lymphomas. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager, GADLEN&#8482;, platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer. Shattuck has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit&#58; www.ShattuckLabs.com.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this press release may constitute &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, including, but not limited to, our expectations regarding plans for our preclinical studies, clinical trials and research and development programs, the anticipated timing for enrollment of our clinical trials, the anticipated timing of the results from our preclinical studies and clinical trials, anticipated timing for preclinical development updates, potential clinical benefit of our product candidates, and expectations regarding the time period over which our capital resources will be sufficient to fund our anticipated operations. Words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;objective,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;develop,&#8221; &#8220;plan&#8221; or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While we believe these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in our filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;)), many of which are beyond our control and subject to change. Actual results could be materially different. Risks and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uncertainties include&#58; the recent and ongoing COVID-19 pandemic&#59; expectations regarding the initiation, progress, and expected results of our preclinical studies, clinical trials and research and development programs&#59; expectations regarding the timing, completion and outcome of our clinical trials&#59; the unpredictable relationship between preclinical study results and clinical study results&#59; the timing or likelihood of regulatory filings and approvals&#59; liquidity and capital resources&#59; and other risks and uncertainties identified in our Annual Report on Form 10-K for the year ended December 31, 2021, filed on March 15, 2022 with the SEC. We claim the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We expressly disclaim any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investor &#38; Media Contact&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conor Richardson</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Director, Finance &#38; Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shattuck Labs, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InvestorRelations&#64;shattucklabs.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i4e95977f5b3741c9bc32d98b05a7f109_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">PART I - FINANCIAL INFORMATION</font></div><div style="margin-bottom:0.08pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Item 1. Financial Statements</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">SHATTUCK LABS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">BALANCE SHEETS</font></div><div style="margin-bottom:0.08pt;margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(In thousands)</font></div><div style="margin-bottom:0.08pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.241%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">March&#160;31, 2022</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31,<br>2021</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">(unaudited)</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">50,743&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">92,268&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Investments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">188,482&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">176,536&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,763&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19,462&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">254,988&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">288,266&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,274&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9,938&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,228&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">381&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">270,490&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">298,585&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Liabilities and Stockholders&#8217; Equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,593&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,012&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued expenses and other current liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14,221&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14,574&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,814&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,586&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Non-current operating lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,738&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred rent</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,213&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">21,552&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">26,799&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">391,055&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">389,408&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated other comprehensive loss</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(527)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(560)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(141,595)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(117,067)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">248,938&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">271,786&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">270,490&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">298,585&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i4e95977f5b3741c9bc32d98b05a7f109_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(Unaudited) </font></div><div style="margin-bottom:0.08pt;margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(In thousands, except share and per share amounts) </font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Collaboration revenue - related party</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,270&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19,187&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,337&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,979&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,356&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Expense from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,166&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14,693&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,166)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(12,423)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other income (expense)&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(362)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">610&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,528)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(11,813)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Unrealized gain (loss) on investments</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(597)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Comprehensive loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,495)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(12,410)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss per share &#8211; basic and diluted</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.58)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.28)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted-average shares outstanding &#8211; basic and diluted</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">42,357,625&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,774,111&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>sttk-20220512.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:277ccaaa-9ac8-485f-a13a-130f0df53a45,g:8a1a2fa4-acd3-4100-ad78-32c9fdee1805-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sttk="http://www.shattucklabs.com/20220512" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.shattucklabs.com/20220512">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20220512_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20220512_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.shattucklabs.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>sttk-20220512_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:277ccaaa-9ac8-485f-a13a-130f0df53a45,g:8a1a2fa4-acd3-4100-ad78-32c9fdee1805-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_6566d4fe-e01b-4430-a0d1-392e51a4f9ca_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b6958648-467b-4552-b0c1-25e1dad22d93_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0b069751-5361-47ba-813d-fb20039aea5a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_b32a26d1-da32-45a1-8944-8038162af2fe_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_953ce59a-2c91-4f19-90b4-3c48835f3728_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_98a330b6-e32f-4e11-b1cd-fb34474359bf_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a1be42cd-2f73-4bcb-aea2-4d57d686e53f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1f18b465-5a29-4b22-b2b7-684c4f513d33_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c27c66d8-ec70-4597-9d64-bf5c22fab7bc_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_02547bf8-d7f4-4e84-8c64-fed184139f2d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f74c466d-1455-42c2-b983-6431183a22b4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8c4df7f4-f10b-4e98-b5df-fed2021478bf_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_e4e92328-633f-4262-a1d3-2114131315f9_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_19d79e20-ae52-4405-b738-5c76b2d7538d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b35f08b1-68e2-4de0-bc67-e82bc4d05d9e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9184a798-9175-4da4-8ffe-1f51abfa6da1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8c7efe27-f645-49d3-8a17-13a4c4673713_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b0833503-917e-48cc-8656-efd5c6aeec4c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_1ee757d0-e542-4de5-bab6-df24cede7564_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ffe5fe25-8992-4454-939f-ae4157923483_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_da44e433-16c6-4f86-b6fa-1a02f6f0de3e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_62585d42-3911-4483-ade8-2da3aeee95be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_07fb4932-4fc4-48c1-acc8-902f66b2f6fc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6f3fe105-4c62-4991-ad7d-fc833f9c2130_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>sttk-20220512_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:277ccaaa-9ac8-485f-a13a-130f0df53a45,g:8a1a2fa4-acd3-4100-ad78-32c9fdee1805-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.shattucklabs.com/role/Cover" xlink:type="simple" xlink:href="sttk-20220512.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5e3167bb-dfa8-445d-b7ca-d38912a03e91" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_DocumentType_5e3167bb-dfa8-445d-b7ca-d38912a03e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7486d909-ed92-4c38-b2de-dc60f8a91f04" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_DocumentPeriodEndDate_7486d909-ed92-4c38-b2de-dc60f8a91f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5054b152-6edb-4bf3-ae2a-282b2121c03a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityRegistrantName_5054b152-6edb-4bf3-ae2a-282b2121c03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ae8a76e2-b7b1-456b-af53-e0c2b34f0db3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ae8a76e2-b7b1-456b-af53-e0c2b34f0db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_18ac5d17-b550-4098-97d5-fb3fc4c2b2f8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityFileNumber_18ac5d17-b550-4098-97d5-fb3fc4c2b2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bf3b4704-422e-444a-be96-3e279da5dd02" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityTaxIdentificationNumber_bf3b4704-422e-444a-be96-3e279da5dd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5ad4ed27-0cb1-42c1-9f6c-7310cd593396" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityAddressAddressLine1_5ad4ed27-0cb1-42c1-9f6c-7310cd593396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_dcb04228-2f1b-40a3-a12a-d8b84fff44af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityAddressAddressLine2_dcb04228-2f1b-40a3-a12a-d8b84fff44af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8d0637b0-4f23-4568-a6c1-e1c2e15044a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityAddressCityOrTown_8d0637b0-4f23-4568-a6c1-e1c2e15044a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_36d3133e-d52e-44da-8485-da8740010358" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityAddressStateOrProvince_36d3133e-d52e-44da-8485-da8740010358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_38d34bc3-347d-4703-8184-8057d569bcbc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityAddressPostalZipCode_38d34bc3-347d-4703-8184-8057d569bcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_aa5607b0-33e1-4330-b210-e5877465f6b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_CityAreaCode_aa5607b0-33e1-4330-b210-e5877465f6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f71d82b1-8f99-4ac5-a0bd-f484d9b7263b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_LocalPhoneNumber_f71d82b1-8f99-4ac5-a0bd-f484d9b7263b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c2dbec7f-d371-4015-8a9e-c45061b63fdb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_WrittenCommunications_c2dbec7f-d371-4015-8a9e-c45061b63fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_f9b9c9b8-6865-4927-8347-507bab328ae1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_SolicitingMaterial_f9b9c9b8-6865-4927-8347-507bab328ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_0ef9b2b6-a3da-4bf7-8038-c164c7484a98" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_PreCommencementTenderOffer_0ef9b2b6-a3da-4bf7-8038-c164c7484a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0dfa602a-7b53-4024-ac2c-efc11868c89b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_0dfa602a-7b53-4024-ac2c-efc11868c89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3d6c530b-d569-4386-bfc5-951100e990f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_Security12bTitle_3d6c530b-d569-4386-bfc5-951100e990f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_09e5ac42-12bc-4008-a20a-f5e869747d7f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_TradingSymbol_09e5ac42-12bc-4008-a20a-f5e869747d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_cb5f5dd1-efbd-4b15-945d-702b4238847e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_SecurityExchangeName_cb5f5dd1-efbd-4b15-945d-702b4238847e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9982296b-338d-49f1-b925-f0c9709c5e88" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityEmergingGrowthCompany_9982296b-338d-49f1-b925-f0c9709c5e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_744f1e8d-fcbb-4cb4-9206-d01c5c6cdc20" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityExTransitionPeriod_744f1e8d-fcbb-4cb4-9206-d01c5c6cdc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_afddda79-10c4-4a6f-9d83-c9708d22ad85" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_EntityCentralIndexKey_afddda79-10c4-4a6f-9d83-c9708d22ad85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e707d0d8-48d6-4d94-b745-1a739b5c6c7f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4845aa02-70c4-402f-a95c-9c8cc6a74490" xlink:to="loc_dei_AmendmentFlag_e707d0d8-48d6-4d94-b745-1a739b5c6c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_2a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2a.jpg
MB5!.1PT*&@H    -24A$4@   F    "8" (   #,5\+:     7-21T( KLX<
MZ0  *2))1$%4>%[MG0=\%-43Q_?NT@BA))! (/0.44%#%Q61" BA5^E2!:1(
M"Z&I]%X$&R!%Y"\M! ,J4A40$*2)(!!*"! "!-)[\I_+P1EN]_;V;LM=-K_]
MW,</)O-FYGW?YF;?VWGS-#DY.0PN$  !$  !$ "!%PEH 00$0  $0  $0(!-
M  $2=P4(@  (@  (<!! @,1M 0(@  (@  ((D+@'0  $0  $0$ 8 <P@A7&"
M% B   B 0 $C@ !9P 8<W04!$  !$!!&  %2&"=(@0 (@  (%# "") %;,#1
M71   1   6$$$""%<8(4"(  "(!  2.  %G !AS=!0$0  $0$$8  5(8)TB!
M  B   @4, ((D 5LP-%=$  !$  !8000((5Q@A0(@  (@$ !(X  6< &'-T%
M 1   1 01@ !4A@G2($ "(  "!0P @B0!6S T5T0  $0  %A!! @A7&"% B
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M@$Q.3&#SR<Y6I)AJ5!3GT#R\=U^&(8-*$  !$  !)0BH)T Z.SNS@6DTBM1
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MVSP>GSD;>^-F0GRBBXMK97]_]WIUK+WY0B>LB(N-HVT>_<<-T[SD;6USR(,
M"(  "$A(P.$"I&U]NQKZ<>XF0OV&1?H80BRIRLG6Z)Q< @8M,Z?V]#?3$^+T
MV;/\^R#?[=1-6\=LM(X,W_/7L>.Y&HS57/6F/4N4> <G7MDVHF@% B   O8F
MH(8 >7[3X&S]I>4,D+FU5;6-AG]N#O7ORR=D9F3R!$B_RE7]>PTQUWSO)S/3
MTS*89]'QA0"I_R'#=%OX&6/%4JZ][PC8!P$0  $0R"60[P/DE6T?I20G4D=X
M J1AQ;71L.7F!OV/U5-3DI*>5_#18\D->!IJ]DKC9CYOM377,&QJL&'":CY
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ML:VLRCD]Y+1(DB-'CGPWT,9<Z/8=.HC_;A7(<\+X\6^\\<+#J[D>"51HE9C
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MR@!)I5,]&YPHY%Z4JKLY.;L5\RKKV4#N5)'*3D[.0C!IM!I=[??X):]M_^+
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M2EB'#1   1   1D(J"= 9F;JSS SN>A8#!F@L51&17%:24U)4<(Z;(  "(
M",A 0#T!LK!'$38?\_5=)659HP:G.I^R?I*:@3(0  $0  'E"*@G0-9LWI:-
MK4*UVLJP='9Q81MJ,+RO,M9A!01   1 0'("Z@F03,FW:[Y</R^@$MZ^I=[^
M4')DG K?^V1&WAA)E51;M.<(V,HX RL@  (@  +B":AJFX<!1^K9#<E)R5ZO
M#Q=/QVH-<8F7PO=6]_=W?D6AF:O5'J(!"(  "(" , (J#)#".@XI$  !$  !
M$. CH*(E5@PT"(  "(  "$A'  %2.I;0! (@  (@H"("") J&DQT!01   1
90#H"_P>L>)^PX- 9RP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140111471231336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 12,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Shattuck Labs, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-2575858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 W. 5th Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">900-4690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">STTK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001680367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>sttk-20220512_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sttk-20220512.xsd" xlink:type="simple"/>
    <context id="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2022-05-12</startDate>
            <endDate>2022-05-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl80L2ZyYWc6MjA4MDkxZTViMDczNGM3NThmZTNiOTU2MjA0ZDliNjcvdGFibGU6NDMwNTNkYWE5ZmNhNDg5YjhlYzc0MGQzZjBkNWRkMzMvdGFibGVyYW5nZTo0MzA1M2RhYTlmY2E0ODliOGVjNzQwZDNmMGQ1ZGQzM18wLTEtMS0xLTE0Mjg2_c743cb3e-062f-431b-8976-e7122e03b19e">0001680367</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl80L2ZyYWc6MjA4MDkxZTViMDczNGM3NThmZTNiOTU2MjA0ZDliNjcvdGFibGU6NDMwNTNkYWE5ZmNhNDg5YjhlYzc0MGQzZjBkNWRkMzMvdGFibGVyYW5nZTo0MzA1M2RhYTlmY2E0ODliOGVjNzQwZDNmMGQ1ZGQzM18xLTEtMS0xLTE0Mjg2_848ed7e1-0726-4357-a4bd-4cdfe5d5be92">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTQ_1d9f910b-84e4-4dc8-86aa-be08ca3dbd54">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl8yMjU_41db24ab-ae4c-4fa1-a53d-f2293471c9d0">2022-05-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTU_8eb49e27-8abf-4f66-b318-89f4cc9e96f5">Shattuck Labs, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YjE0NzNjYmU5YzcwNDE3ZDg2ZDc0ZmRjMzE0M2ZhMGUvdGFibGVyYW5nZTpiMTQ3M2NiZTljNzA0MTdkODZkNzRmZGMzMTQzZmEwZV8wLTAtMS0xLTE0Mjg2_570b4ff6-4e9f-48c2-b763-1dd18bab1a1d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YjE0NzNjYmU5YzcwNDE3ZDg2ZDc0ZmRjMzE0M2ZhMGUvdGFibGVyYW5nZTpiMTQ3M2NiZTljNzA0MTdkODZkNzRmZGMzMTQzZmEwZV8wLTEtMS0xLTE0Mjg2_600d36c8-37b0-4f16-8236-e579f8f3fd5a">001-39593</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YjE0NzNjYmU5YzcwNDE3ZDg2ZDc0ZmRjMzE0M2ZhMGUvdGFibGVyYW5nZTpiMTQ3M2NiZTljNzA0MTdkODZkNzRmZGMzMTQzZmEwZV8wLTItMS0xLTE0Mjg2_af4fc0d3-7185-4965-bbdb-4543a9527309">81-2575858</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTY_b54f7276-585f-429a-bc0a-ca2f2ecf0dd2">500 W. 5th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MjE_ab990f7d-43ee-40d1-a5c8-c6d231e0a146">Suite 1200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTc_9ea9f573-488f-496b-8944-4fe8d5e5f2f2">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MTg_b2ff93f8-a2b8-423b-8c11-4fdf61654492">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MjM_9ccbf416-a751-43aa-a451-71d8a06d0eda">78701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl8zNjY_dcc84cd2-7b76-44ec-b804-4d1204588a36">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGV4dHJlZ2lvbjowMjhhNjNkNWRkMGM0YjgzOGQzZTE3MGU0ODExNTY5Zl81MjQ_67d1c586-410b-473f-b1cd-47e22e8de4b3">900-4690</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl8xLTAtMS0xLTE0Mjg2_b5dc87a2-8776-4db6-908b-73b8e804fd00">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl8yLTAtMS0xLTE0Mjg2_a35ade2d-2005-4f70-a71a-98e9d3aae3d3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl8zLTAtMS0xLTE0Mjg2_024445a3-19ef-4507-9e14-5de10bf652c8">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6YTMxYWZkNzBlYWU1NDRjNmI3YzlmNjg1YWViYTBmOTYvdGFibGVyYW5nZTphMzFhZmQ3MGVhZTU0NGM2YjdjOWY2ODVhZWJhMGY5Nl80LTAtMS0xLTE0Mjg2_504b034b-f553-4b87-925e-417b64abd356">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6M2I0MjhhN2YyZmRmNDZiNDg2MGZiNWI5ZjcxZjNjYTIvdGFibGVyYW5nZTozYjQyOGE3ZjJmZGY0NmI0ODYwZmI1YjlmNzFmM2NhMl8xLTAtMS0xLTE0Mjg2_19f06ca9-0d45-4c5b-80f1-30b608db958b">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6M2I0MjhhN2YyZmRmNDZiNDg2MGZiNWI5ZjcxZjNjYTIvdGFibGVyYW5nZTozYjQyOGE3ZjJmZGY0NmI0ODYwZmI1YjlmNzFmM2NhMl8xLTEtMS0xLTE0Mjg2_c10d3f17-4aa7-4218-80eb-f3187e3eac49">STTK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6M2I0MjhhN2YyZmRmNDZiNDg2MGZiNWI5ZjcxZjNjYTIvdGFibGVyYW5nZTozYjQyOGE3ZjJmZGY0NmI0ODYwZmI1YjlmNzFmM2NhMl8xLTItMS0xLTE0Mjg2_1bc5b1fa-1f08-4e51-8a47-9855241b17de">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6Y2ExOTdiMDgwMzRjNDIyZmFjOWRmMTY1MTczZDg5MjAvdGFibGVyYW5nZTpjYTE5N2IwODAzNGM0MjJmYWM5ZGYxNjUxNzNkODkyMF8xLTEtMS0xLTE0Mjg2_823a916b-9fb5-4853-a26a-bbfab4f86835">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MzU4OTA5ZjQwYjQyMmI4NTYzYmI2NTg1Y2NmZmZiL3NlYzo4ODM1ODkwOWY0MGI0MjJiODU2M2JiNjU4NWNjZmZmYl8xL2ZyYWc6MDI4YTYzZDVkZDBjNGI4MzhkM2UxNzBlNDgxMTU2OWYvdGFibGU6Y2ExOTdiMDgwMzRjNDIyZmFjOWRmMTY1MTczZDg5MjAvdGFibGVyYW5nZTpjYTE5N2IwODAzNGM0MjJmYWM5ZGYxNjUxNzNkODkyMF8yLTEtMS0xLTE0Mjg2_30bbac40-21dc-4583-adaf-573bf3ecb68a">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $ PK%0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " ! ,*Q448L"W^T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R';9#B;-I:.G#@8K;.QF;+4UBV-C:R1]^SE9FS*V!]C1TN]/
MGT"-B<J$A,\I1$SD,-^-ONNS,G'-3D11 61S0J]S71)]:1Y"\IK*,QTA:O.A
MCPB2\P?P2-IJTC !J[@06=M8HTQ"32%=\-8L^/B9NAEF#6"''GO*(&H!K)TF
MQO/8-7 #3##"Y/-W >U"G*M_8N<.L$MRS&Y)#<-0#ZLY5W80\/:T>YG7K5R?
M2?<&RZ_L%)TCKMEU\NMJ\[C?LE9R*2M^7PFY%UQQJ;AXGUQ_^-V$?;#NX/ZQ
M\56P;>#77;1?4$L#!!0    ( $ PK%297)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MHM\WC$J+4_12&3B3%[<19V!D]@7X?J64>6_8@WGYO\KX7U!+ P04    " !
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( $ PK%11BP+?[0   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( $ PK%297)PC$ 8  )PG   3
M      "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 0#"L
M5*XLL(1;!   8Q$  !@              ("!# @  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( $ PK%2?H!OPL0(  .(,   -
M      "  9T,  !X;"]S='EL97,N>&UL4$L! A0#%     @ 0#"L5)>*NQS
M    $P(   L              ( !>0\  %]R96QS+RYR96QS4$L! A0#%
M  @ 0#"L5*K$(A8S 0  (@(   \              ( !8A   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( $ PK%0D'INBK0   /@!   :
M  "  <(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M $ PK%1ED'F2&0$  ,\#   3              "  :<2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  /$3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sttk-20220512.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="sttk-20220512.htm">sttk-20220512.htm</File>
    <File>sttk-20220512.xsd</File>
    <File>sttk-20220512_lab.xml</File>
    <File>sttk-20220512_pre.xml</File>
    <File>sttk_1q2022earningsrelease.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sttk-20220512.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "sttk-20220512.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sttk-20220512_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sttk-20220512_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sttk-20220512.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sttk",
   "nsuri": "http://www.shattucklabs.com/20220512",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20220512.htm",
      "contextRef": "ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.shattucklabs.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20220512.htm",
      "contextRef": "ib554c2dfc00f4167abeff22d5676a1c5_D20220512-20220512",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001680367-22-000014-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001680367-22-000014-xbrl.zip
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M62MSC(L?Q@5Y0$]B>8H)VS9@Y-BM-VM5=-3<:]:.T#*!;"*\1[7]X\-ZLP[
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MX I9#(RA/XHR,F#Q*(VF*"59F 93T;)H$'LPU2(,E'>YD+4V@GZ XPRF\[(
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MX<.](BN5GI'I69W]<6PW<C>6H^TY,)[.SCB!NC7[0<"V1YP,W*T)50'>WG#
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M9EZ]?;%Y)UG]4QEO7_P?4$L#!!0    ( $ PK%3PT,1)! <  !4U   5
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MB7>*!P[W[G_H7KK_T1SN_0=02P,$%     @ 0#"L5!1P^4^>'@  BR,! !X
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M+3(P,C(P-3$R+FAT;5!+ 0(4 Q0    ( $ PK%1AVU@%:P(  'H'   1
M          "  0 6  !S='1K+3(P,C(P-3$R+GAS9%!+ 0(4 Q0    ( $ P
MK%2**;K0\0H  /AD   5              "  9H8  !S='1K+3(P,C(P-3$R
M7VQA8BYX;6Q02P$"% ,4    " ! ,*Q4\-#$200'   5-0  %0
M    @ &^(P  <W1T:RTR,#(R,#4Q,E]P<F4N>&UL4$L! A0#%     @ 0#"L
M5!1P^4^>'@  BR,! !X              ( !]2H  '-T=&M?,7$R,#(R96%R
F;FEN9W-R96QE87-E+FAT;5!+!08     !0 % % !  #/20     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
